This study, called the HeartBeam ECG Registry, is collecting information about your heart's electrical activity using a device called the HeartBeam System. This is an observational study, meaning you won't receive a new treatment, but your routine electrocardiogram (ECG) data will be recorded. The goal is to create a large, de-identified database of ECG recordings from people with various heart rhythm conditions like atrial fibrillation, atrial flutter, bradycardia (slow heart rate), and tachycardia (fast heart rate). This database will help with future research and regulatory approvals for the HeartBeam System. You can join if you are 18 or older, are already having an ECG as part of your regular care, and can give written consent. The study aims to enroll 600 participants, but its current recruitment status is unclear.

Study design

This is an observational study aiming to enroll 600 participants. It is not a treatment study, but rather collects data from routine care.

What's involved

You will use the HeartBeam System to capture your heart's electrical activity during an ECG that is already part of your standard medical care.

Compensation

Not stated in the trial record.

Follow-up

The primary goal is to create a dataset, measured at 2 years, but individual participant follow-up is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.